Lancet Market 2020 – Leading Manufactures, Regions, Drivers, Analysis And Forecasts Till 2024

 Globally, lancets are being utilized by patients who are affected by endocrine related complications, cardiovascular issues, and many others. Lancets are being used for diabetes/glucose test, tests in infants, heel-stick screening tests, as well as for scarred emergency patients or severely burned patients. The global lancet market is growing at an exponential rate and it is expected to grow at a CAGR of 11.3% during 2016 to 2022.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/2078 

The increasing prevalence of diabetes and growing incidence number of contagious and non-contagious diseases has been the major factor for influencing the growth of the market. Incidence of contagious diseases is increasing rapidly on a global level. According to the WHO, it has been calculated that, infectious diseases like plaque which is also known as black death has an estimated 50 million deaths in the 14th century, this infectious disease can be a serious disease if not treated, this disease has a case fatality ratio of around 30%-60%, as of 2013 there were 783 cases worldwide which includes 126 deaths.

The global lancet market appears to be oligopolistic owing to the presence of large players active in the regional market. The market is also characterized by a reasonable degree of brand loyalty where establishing a brand name is difficult for newcomers. However, the cost involved in manufacturing setup is low to medium which discreetly comfort the new entrants to enter in the market easily.  Developments in the medical device industry are made to simplify the diagnosis, prevention, and treatment of various diseases. One of such device is lancet, which is capturing a huge market share due to its application. Safety lancets and personal lancets being the two major types of the lancets are dominating the global lancet market.

Industry Updates

June, 2016: F. Hoffmann-La Roche AG received European approval of Avastin Drug in combination with Tarceva for cancer patients with a specific type advance lung cancer.

January, 2016: Catalent Inc., a company involved in biologics announced its research collaboration with Roche on Smartag(TM) technology. Catalent claims Roche will pay Catalent an up-front fee of $1 million. Roche to provide additional research funding during the initial phase of the collaboration between these two companies. 

October, 2015: BD announced the acquisition of GenCellBio systems, an Irish biotech company that has developed proprietary technologies that address key biological analysis protocols, for an undisclosed consideration. The acquisition is expected to improve the BD’s Next Generation Sequencing line of products. 

August, 2015: Roche Holding AG acquired GeneWEAVE to strengthen offerings in microbiology diagnostics. Roche will pay GeneWEAVE shareholdsers $190 million upfront and up to $235 million in contingent product related milestones.

March, 2015: BD completed the acquisition of CareFusion Corporation (CareFusion) for $12.2 billion. CareFusion will operate as a wholly-owned subsidiary of BD. The acquisition is intended to enhance the medication management and patient safety solutions provided by BD. 

March, 2015: BD announced the acquisition of CRISI Medical Systems, a medical technology company focused on providing safety and delivery of IV injectable medications. The acquisition will strengthen BD’s position in addressing preventable medication errors and improve care delivery efficiencies. 

Global Lancets Market – Regional Analysis

The oligopolistic nature of the market with North America at its prime holding the largest regional share. The factors contributing to this major share include the well-established healthcare infrastructure and the high income generating end users. As of now the medical device industry is majorly established in the U.S. and Europe. But trends are showing enormous growth opportunity in Asia, wherein China will play a prominent role in both usage and development of medical devices.

Moreover, in terms of volume; manufacturers from China are anticipated to capture a large portion of the market, companies such as Guangzhou IMPROVE MEDICAL Technology Co. Ltd, SteriLance Medical (Suzhou) Inc., and others are contributing to this major portion. These companies have established their manufacturing unit worldwide.

Global Lancets Market - Competitive Analysis

Many key players involved in this market are keen in introducing new advanced safety lancets for the treatment of various contagious diseases. HTL-STREFA S.A. accounted for major market share of global lancet market, with more than 35% of market share. The large share of the company is attributed to the high demand for safety lancet globally. Moreover, this company has a strong sales and distribution network and this company also provides after sales services and help which play a major role in the satisfaction of the customers. F. Hoffmann-La Roche AG accounts for approximately 22% which can be attributed to their product the ACCU-CHEK which is one of the safety lancets having high demand in the market.

The major players in the market which have global operations of the Lancet market, and are consistently working for the development of the following technology are F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Greiner Bio One International GmbH, Improve Medical Technology Co. Ltd, Terumo Medical Corporation, Bayer Cropscience Limited, HTL-STREFA S.A, Sarstedt AG & Co and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/lancet-market-2078

The Costochondritis Market Grows Incredibly; Confirms Mrfr Unleashing Industry Prognostications Up To 2023

 Market Scenario

Costochondritis is an inflammatory condition of the cartilage which connects a rib to the sternum. It is sometimes called chest wall pain, costosternal chondrodynia, or costosternal syndrome. The pain caused by costochondritis might be similar to that of a heart attack. Costochondritis is a common cause of chest pain in adolescents and children. It is estimated that the global costochondritis treatment market is expected to register an increasing CAGR during the forecast period from 2018 to 2023.

The factors causing costochondritis can be injury in chest, physical strain, osteoarthritis, arthritis, ankylosing spondylitis, and tumors (cancerous or noncancerous).  Also, costochondritis may be caused by bacterial, viral, and fungal infections. According to the Centers for Disease Control and Prevention, August 2018, it has been estimated that 22.7% of the US adults had some form of rheumatoid arthritis from 2013 to 2015. The growing percentage of arthritis patients would support the costochondritis market positively.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6500

However, factors such as the high cost of surgical procedures, expensive treatments, and side effects related to treatments are expected to restrict the market growth during the forecast period.

Segmentation

The global costochondritis market is segmented on the basis of diagnosis, treatment, and end-user. The costochondritis market, by diagnosis, is categorized into various tests. The test is sub-segmented into echocardiogram, electrocardiogram, stress tests, cardiac catheterization, chest X-ray, cardiac MRI, and CT scan. On the basis of treatment, the market is segmented into medications, therapy, and surgery.

The medications treatment is further sub-segmented into nonsteroidal anti-inflammatory drugs, narcotics, antidepressants, and anti-seizure drugs. Therapy is sub-segmented into stretching exercises and nerve stimulation. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, research centers, and others.

On the basis of region, the global costochondritis market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the UAE, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

Key players

Some of the key players in the global costochondritis market are KemPharm, GlaxoSmithKline plc, Biovail Corporation, Aurobindo Pharma, Pfizer Inc., Recro Pharma Inc., LUPIN, Bausch Health Companies Inc., Avenue Therapeutics, and others.

Regional Market Summary

It is estimated that North America dominated the global costochondritis market owing to the increased cardiac diseases, increasing prevalence of syphilis, innovations in clinical practice, heart research, and access to heart treatments in this region. According to the Centers for Disease Control and Prevention (CDC), September 2017, the total syphilis cases reported to CDC increased by 17.8% during 2015 to 2016. The increase in the cases of syphilis supports the market growth in this region.

Europe stood the second largest in the costochondritis market owing to increasing hypertension and heart attack cases. According to the Public Health England in January 2017,

high blood pressure is the third highest risk factor for disease in the UK. It affected one in four adults and around 12.5 million people in 2015 in England. This number is expected to increase during the forecast period.  Such a high incidence of high blood pressure supports the growth of costochondritis in this region.

Asia-Pacific was estimated to be the fastest growing region for the global costochondritis market in 2017. The market is expected to witness growth owing to the rising prevalence of heart problems, car accidents, and changing lifestyle.

The Middle East and Africa holds the least share in the global costochondritis market due to the presence of low health expenditure, low awareness of innovative technology, and economically diverse countries. However, the market is expected to witness growth due to increasing cardiac care programs and an increase in investments in research and development in the Middle East.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/costochondritis-market-6500

Worldwide Healthcare Claims Management Market Witness A Remarkable Growth Projected By 2023

 Market Scenario

Global healthcare claims management market is expected to grow significantly over the forecast period. It is estimated that the global healthcare claims processing market is expected to register a CAGR ~ 5.37% during the forecast period of 2018–2023. Healthcare claims management process comprises of various tasks such as organization, billing, filling, updating, and processing of medical claims related to the diagnosis, treatment, and medication of patients.

The global market is driven by factors such as increase in ageing population, rise in incidence of chronic diseases, improved focus on healthcare quality services and advent of innovative treatments & technologies.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6376

Factors such as increasing concerns regarding the patient data safety and security limit and data breaches and loss of confidentiality, lack of skilled IT professionals in healthcare are restraining the growth of medical claims management solutions market. According to the National Health Insurer Report Card published in 2011 by American Medical Association (AMA), around $17 billion a year (on an average) could be saved by eliminating errors in claims.

Segmentation

The global healthcare claims management market has been segmented into component, delivery mode type and end-user. The market, based on component, has been segmented into software and services. The market, by delivery mode, has been segmented into on-premise and cloud based. The market, by type, has been segmented into integrated and standalone. The market, by end-user has been segmented into healthcare payers and providers.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The healthcare claims management market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European healthcare claims management market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The healthcare claims management market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The healthcare claims management market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

Cerner Corporation (US), McKesson Corporation (US), Athenahealth (US), eClinicalWorks (US), Optum, Inc. (US), Conifer Health Solutions (US), nThrive (US), Avaya Inc. (USA), Oracle Corporation (US), Infor Inc. (US), Allscripts Healthcare Solutions, Inc. (US), Accenture plc. (Ireland), IBM Corporation (US), Cognizant Technology Solutions Corporation (US) and Genpact Limited (US) are some of the key players in the global healthcare claims management market.

Regional Market Summary

Geographically, the Americas is expected to dominate the global healthcare claims management market due to the growing HCIT investments in the region and the presence of regulatory mandates favouring the implementation of healthcare claims management solutions.

Europe is expected to hold the second largest position in the global healthcare claims management market. The market growth in this region is because of the rise in prevalence of chronic diseases, presence of well-established healthcare system and increase in insurance coverage.

Asia-Pacific is estimated to be the fastest growing region in the market due to the improved healthcare infrastructure and increasing geriatric population.

On the other hand, the Middle East & Africa has the least share of the market. This is due to low technological advancements in the field of healthcare IT.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/healthcare-claims-management-market-6376

Blood Group Typing Industry Overview By Growth Factors, Product Chain Value, Competitors Analysis And Forecast 2023

 Market Scenario

Global blood group typing market size is expected to grow significantly over the forecast period. It is projected to grow at a CAGR of 10.2% over the assessment period. Blood group typing is a method of determining the type of blood group of an individual.  Blood group typing is a mandatory requirement before blood transfusion to examine the compatibility between the donor and recipient blood group. Additionally, blood typing is of significant importance in pregnant women in cases where the father of the baby has RhD positive blood group and the mother has RhD negative blood group. The global blood group typing has witnessed significant growth owing to the technological advancements in blood group detections methods. Technological advancements such as quantum dots (QDs) and magnetic beads in assays improve identification and thus enhance the clinical safety of the blood transfusion.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6410

The factors such as growing demand for blood products need for blood grouping during prenatal testing, increasing number of road incidents, growing number of road accidents and trauma cases which requires a blood transfusion, the rise in blood donations, and growing usage of blood typing in the forensic sciences. According to The American National Red Cross, about 21 million blood components are transfused each year in the US. Following the same source, each year, an estimated 6.8 million people in the US donate blood.

However, the stringent regulatory requirements for blood transfusion may hinder the growth of the global blood group typing market.

Segmentation

The global blood group typing market has been segmented into technique, test type, product and service, and end user.

The market, by technique, has been segmented into PCR-based and microarray techniques, assay-based techniques, massively parallel sequencing, and others.

The market, by test type, has been segmented into antibody screening, HLA typing, ABO blood tests, cross-matching tests, and antigen typing.

The global market, on the basis of product and service, has been segmented into consumables, instruments, and services. The consumables segment has been segmented into antisera reagents, red blood cells reagents, anti-human globulin reagents, and blood bank saline.

On the basis of end user, the market has been segmented into hospitals, blood banks, clinical laboratories, and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The blood group typing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European blood group typing market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The blood group typing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The blood group typing market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

Bio-Rad Laboratories, Inc., Grifols International, S. A., Beckman Coulter, Immucor, Inc., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, Bag Healthcare GmbH, Rapid Labs, AXO Science, Agena Biosciences, Inc., Day Medical SA, and Merck KGaA are some prominent player in the market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/blood-group-typing-market-6410

Biopreservation Market 2020 - Shares, Revenue, Analysis And Forecasts Till 2023

 Market Scenario

The global biopreservation market size is expected to grow during the forecast period (2018–2023) at a CAGR ~11.2%.

Biopreservation is a use of natural flora and its antibacterial products to preserve biological material. Biopreservation is playing an important role in healthcare and food industry to preserve the biological material or food product for a long time. The increasing expenditure on healthcare, growing demand for stem cell preservation and awareness about its use with regards to treatment of diseases are expected to drive the growth of the market. Moreover, increasing awareness about personalized medicines and its applications are contributing to the growth of the market. According to the US Food and Drug Administration (FDA), The department has approved 16 personalized medicines in the year 2017, which accounts for 20% of total drug approvals.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6407

The rising high price of biopreservation instruments and its maintenance, stability issues related to the specimen and lack of skilled personnel for handling the biopreservation process may hamper the growth of the market during the assessment period.

Segmentation

The global biopreservation market has been segmented on the basis of product, biospecimen, and application.

On the basis of product, the market has been classified as media and equipment. The media subsegment has been further divided into nutrient media, sera, and growth factors and supplements. The equipment segment has been further divided into temperature control systems, accessories, alarms & monitoring systems, incubators, centrifuges, and other equipment. The temperature control systems segment has been further classified as freezers, cryogenic storage systems, thawing equipment, and refrigerators. The biospecimen segment has been divided into human tissue samples, organs, stem cells, and other biospecimens.

The market, by source, has been segmented into regenerative medicine, biobanking, and drug discovery. On basis of regenerative medicine, the market has been divided into cell therapy, gene therapy, and others. Biobanking segment includes human egg, human sperm, and veterinary IVF.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The biopreservation market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European biopreservation market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The biopreservation market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The biopreservation market in the Middle East & Africa has been segmented into the Middle East and Africa.

Regional Market Summary

The Americas are likely to dominate the global biopreservation market owing to the adoption of advanced technology, increasing spending on healthcare R&D, the presence of a well-established healthcare system, and increasing in-house sample storage in hospitals and research institutes. Moreover, presence and recent merger and acquisition activities by market players in the region are contributing to the growth of the market.  For instance, in 2017, Cesca Therapeutics Inc. has acquired Sacramento’s SynGen Inc. for USD 1 million with this acquisition company has managed to add cell separation and cord blood processing products in their portfolio.

The European market is expected to be the second-largest biopreservation market. The market growth in this region can be attributed to the increasing number of births and with-it continuous increase in demand for umbilical cord preservation. According to the European Commission, in the year 2016 more than 5.1 million babies were born in Europe.  Moreover, a growing number of sperm and egg banks is contributing to the growth of the market in this region.

Asia-Pacific is expected to be the fastest-growing biopreservation market during the forecast period owing to the increasing population in the region, increasing awareness about stem cell preservation and continuous development in the healthcare sector due to government funding.

The market in the Middle East & Africa is expected to account for the smallest share of the global biopreservation market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Key Players

Some of the key players in the global biopreservation market are Thermo Fisher Scientific, Inc, VWR International, LLC., CUSTOM BIOGENIC SYSTEMS., BioLifeSolutions Inc., BioCision., Sigma-Aldrich Co., QIAGEN, Lifeline Scientific, Cesca Therapeutics Inc., Core Dynamics, Ltd., Princeton CryoTech, Biomatrica, Inc., Panasonic Biomedical,  Inc., Chart Industries, and ATLANTA BIOLOGICALS

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/biopreservation-market-6407

Global Vitamin test Market Positive Growth And Forecasts By 2023

 Market Highlights

The Vitamin test market growth is expected to witness tremendous boost owing to the rising prevalence of vitamin deficiency. Other key factors such as the change to sedentary lifestyle, increase in smoking, and increasing consumption of junk food and packaged food, growing geriatric population, rising consumer awareness for vitamin benefits, and technologically advanced laboratories are contributing towards the growth of the market.  However, factors such as, high cost of vitamin test, limitations of the tests like false positives and false negatives and lack of awareness in developing countries are expected to restrict the market growth during the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6377

Segmentation

The global Vitamin test market is segmented on the basis of type, technology, and end-user. the vitamin test market, by type, is categorized into vitamin B12 & folic acid test,folic acid (folate) test , carotene (beta carotene) test, vitamin K1 test, vitamin E test, vitamin d 25-dihydroxy (calcitriol) test, vitamin C test, vitamin B12 test, vitamin B6 test, vitamin B5 test, vitamin B3 (niacin) test, vitamin B2 (riboflavin) test, vitamin a (retinol) test, vitamin B1 test. On the basis of Technology, the market is segmented into high-performance liquid chromatography (HPLC), radioimmunoassay, ELISA tests, chemiluminescent immunoassay (CLIA)and liquid chromatography-tandem mass spectrometry. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, research centers, and others.

Regional Analysis

The Americas is the largest in the market owing to the increasing prevalence of vitamin deficiency and growing healthcare expenditure. According to the The United States Department of Agriculture in 2014, 50% of Americans are deficient in vitamin A, vitamin C, and magnesium. Such a high incidence of vitamin deficiency drives market growth in this region.

Europe (UK, Belgium, France, and Netherlands) is the second largest vitamin test market during the forecast period. The increasing in awareness for vitamins and vitamin testing drives the market in this region. The European Laboratory of Nutrients (ELN) is an advanced laboratory for testing the nutrient levels in European population. Every year European Laboratory of Nutrients (ELN) organizes an international symposium titled ‘Advanced Clinical Nutrition - Nutrients for Prevention and Cure of Disease'. Thus enhancing vitamin testing market in this region.

Asia-Pacific was projected to be the fastest growing region for the global vitamin test market in 2017. The market is expected to witness growth owing to the rising prevalence of chronic diseases in this region. Also, the presence of technologically advanced countries like China and Japan in this region is expected to influence the market growth in this region.

The Middle East and Africa accounts for the least share due to low per capita income and lack of availability of well-trained healthcare professionals. However, the rising healthcare services both at the hospital level and in the community are expected to influence the market in a positive way.

Key Players

Some of the key players in the global Vitamin test market are VitaMe Technologies Inc., R-Biopharm AG, Abbott Laboratories, ImmunoDiagnostics Inc., F. Hoffman-La Roche, Siemens AG, Diazyme Laboratories, DiaSorin S.p.A, ORGENTEC Diagnostika GmbH and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/vitamin-test-market-6377

The Dental Practice Management Software Market Staggering Double Digit Cagr Driven By Advanced & Cost Effective Technologies Forecasts Till 2023

 Market Research Future (MRFR)’s study projects healthy growth for the global dental practice management software market in the forthcoming years.  The latest developments in oral healthcare technologies have paved the way for the adoption of software all across the world. Additionally, the increasing awareness about oral healthcare coupled with rising dental healthcare expenditure is expected to favor the expansion of the market over the next couple of years.

The exponential geriatric population has opened new avenues of growth opportunities for service providers in the oral healthcare industry. According to data published by World Population Prospects: the 2017 Revision, the population of older people, over 60 years, is expected to get doubled by 2050. It is anticipated to augment the oral healthcare industry. This, in turn, is prognosticated to accelerate the adoption of dental practice management software in the industry.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6507

The growth trajectory of the market is guided by the rising technological advancements in the dental healthcare industry and its large-scale adoption. The need for better technology for enhanced efficiency has intensified in the dental healthcare industry. The large-scale prevalence of dental disorders owing to the changing lifestyle and food habits is another major factor responsible for complementing the growth of the global market. It is likely to accelerate the revenue creation for the market participants in the foreseeable future.

The market scenario looks attractive at present and is forecasted to remain highly lucrative in the coming years. Furthermore, investments are likely to flow towards the global dental practice management software market over the next couple of years. Nevertheless, lack of skilled personnel remains an impediment to the market proliferation.

Companies Covered

Some of the global dental practice management software market companies are Curve Dental, Practice Web, Henry Schein, NextGen Healthcare Information Systems, LLC., Carestream Dental, DentiMax, Patterson Dental, Allscripts Healthcare Solutions, and Dovetail Dental Software.

Report Overview

This MRFR report presents a comprehensive analysis of the key market trends and an outlook for product segments and major regions highlighting the growth trajectories during the assessment period. It reveals that dental practice management software finds application in invoicing/billing, charting, patient management, insurance management, and others. A detailed analysis is also included based on on-premise, web-based, and cloud-based deployment mode. The regional analysis of the market spans across North America, Europe, Asia Pacific, and the Rest of the World.

Report Coverage

Historical market trends, forecast, key player’s market share analysis, market dynamics, and market factor analysis which covers supply chain and Porter’s five forces analysis of the market. The report also encompasses market value by region as well as by segmentation, and country-level analysis for each market segment.

Research Methodology

MRFR leverages its industry expertise for delivering actionable insights into the markets. An in-depth study of the market elements influencing the forecast is performed for drawing insightful conclusions. The information presented in our reports are backed by data sourced through extensive primary and secondary research. Top-down and bottom-up approaches are employed for authenticating the accuracy of the market size and revenue estimation. A multi-layer verification process further affirms the credibility of the quantitative and qualitative data available in our reports.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-practice-management-software-market-6507